In this Dr. Shanthi Viswanathan, Clinical neurologist at Hospital Kuala Lumpur in Malaysia, shares insights on the current DMTs available in Malaysia, the advocacy work carried out to improve access to DMTs including the importance of the National Essential Medicines List in Malaysia, its potential as an advocacy tool for improving access to MS treatments, and how it has helped to bring about positive change for other conditions like Hepatitis C treatments.
